186 related articles for article (PubMed ID: 26335771)
21. Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.
Kwon YM; Hwang HS; Lee JS; Ko EJ; Yoo SE; Kim MC; Lee YN; Kim KH; Song JM; Lee S; Moore ML; Kang SM
Antiviral Res; 2014 Apr; 104():1-6. PubMed ID: 24462695
[TBL] [Abstract][Full Text] [Related]
22. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
[TBL] [Abstract][Full Text] [Related]
23. A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque.
Jenkins T; Wang R; Harder O; Xue M; Chen P; Corry J; Walker C; Teng M; Mejias A; Ramilo O; Niewiesk S; Li J; Peeples ME
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177201
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
Sawada A; Yunomae K; Nakayama T
Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
[TBL] [Abstract][Full Text] [Related]
25. Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure.
Ma J; Gong T; Luo T; Li S; Zhong L; Zhao X; Mei C; Bu H; Jia Z; Kuang X; Wang X; Fu Z; Tian D
Front Immunol; 2024; 15():1377374. PubMed ID: 38745662
[TBL] [Abstract][Full Text] [Related]
26. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.
Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA; Moore ML
J Virol; 2016 Aug; 90(16):7508-7518. PubMed ID: 27279612
[TBL] [Abstract][Full Text] [Related]
27. The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.
Boukhvalova MS; Blanco JC
Curr Top Microbiol Immunol; 2013; 372():347-58. PubMed ID: 24362698
[TBL] [Abstract][Full Text] [Related]
28. A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
Grieves JL; Yin Z; Garcia-Sastre A; Mena I; Peeples ME; Risman HP; Federman H; Sandoval MJ; Durbin RK; Durbin JE
Vaccine; 2018 Jun; 36(26):3842-3852. PubMed ID: 29779923
[TBL] [Abstract][Full Text] [Related]
29. Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
Sawada A; Nakayama T
Microbiol Immunol; 2016 Apr; 60(4):234-42. PubMed ID: 26865035
[TBL] [Abstract][Full Text] [Related]
30. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
31. AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats.
Sawada A; Komase K; Nakayama T
Vaccine; 2011 Feb; 29(7):1481-90. PubMed ID: 21185852
[TBL] [Abstract][Full Text] [Related]
32. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
[TBL] [Abstract][Full Text] [Related]
33. Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.
Russell MS; Creskey M; Muralidharan A; Li C; Gao J; Chen W; Larocque L; Lavoie JR; Farnsworth A; Rosu-Myles M; Hashem AM; Yauk CL; Cao J; Van Domselaar G; Cyr T; Li X
Front Immunol; 2019; 10():597. PubMed ID: 30984178
[TBL] [Abstract][Full Text] [Related]
34. A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.
Lindell DM; Morris SB; White MP; Kallal LE; Lundy PK; Hamouda T; Baker JR; Lukacs NW
PLoS One; 2011; 6(7):e21823. PubMed ID: 21789184
[TBL] [Abstract][Full Text] [Related]
35. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
[TBL] [Abstract][Full Text] [Related]
36. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
[TBL] [Abstract][Full Text] [Related]
37. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
[TBL] [Abstract][Full Text] [Related]
38. Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.
Sharma A; Wendland R; Sung B; Wu W; Grunwald T; Worgall S
Vaccine; 2014 Sep; 32(43):5761-8. PubMed ID: 25171847
[TBL] [Abstract][Full Text] [Related]
39. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
40. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
